Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
EMERYVILLE, Calif., April 24, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, wi
PR NewswireApr 24 16:05 ET
Health Check: How Prudently Does Dynavax Technologies (NASDAQ:DVAX) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Simply Wall StApr 8 06:12 ET
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dynavax Technologies Corp: Appoints Ryan Spencer to Serve as Interim Chief Financial Officer While Kelly MacDonald Is on Maternity Leave
Dow JonesApr 1 16:42 ET
Dynavax (NASDAQ:DVAX) Offers Potentially Robust Growth at a Rich Valuation
TipRanksMar 19 10:09 ET
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
Yahoo FinanceMar 4 23:53 ET
11 Best Small Cap Pharma Stocks to Invest In
Yahoo FinanceMar 4 20:28 ET
Dynavax Technologies(DVAX.US) Officer Sells US$262.32K in Common Stocks
$Dynavax Technologies(DVAX.US)$ Officer Burgess Justin sold 20,526 shares of Common Stocks on Mar 1, 2024 at an average price of $12.78 for a total value of $262.32K.Source: Announcement What is state
moomoo NewsMar 4 18:10 ET
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...
PR NewswireFeb 27 18:54 ET
The Dynavax Technologies Corporation (NASDAQ:DVAX) Annual Results Are Out And Analysts Have Published New Forecasts
It's been a good week for Dynavax Technologies Corporation (NASDAQ:DVAX) shareholders, because the company has just released its latest yearly results, and the shares gained 2.7% to US$12.75. R
Simply Wall StFeb 24 09:25 ET
Q4 2023 Dynavax Technologies Corp Earnings Call
Yahoo FinanceFeb 23 06:38 ET
Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue
Dynavax Technologies (DVAX) reported breakeven Q4 earnings late Thursday, compared with net income of $0.45 per diluted share a year earlier. Analysts polled by Capital IQ expected a loss of $0.02 per
MT NewswiresFeb 23 05:19 ET
Earnings Call Summary | Dynavax Technologies(DVAX.US) Q4 2023 Earnings Conference
The following is a summary of the Dynavax Technologies Corporation (DVAX) Q4 2023 Earnings Call Transcript:Financial Performance:Dynavax reported a significant increase in net product revenue for 2023
moomoo AIFeb 23 00:33 ET · Conference Call
Dynavax Technologies: A Stable Hold Amidst a Catalyst-Deficient Forecast
TipRanksFeb 23 00:15 ET
Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023
Yahoo FinanceFeb 22 16:44 ET
Dynavax Technologies Sees FY24 Net Product Revenue $265M-$280M Vs $290.628M Est.
Dynavax Technologies Sees FY24 Net Product Revenue $265M-$280M Vs $290.628M Est.
BenzingaFeb 22 16:37 ET
Dynavax Technologies: Q4 Earnings Insights
Dynavax Technologies (NASDAQ:DVAX) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsDynavax Technologies mi
BenzingaFeb 22 16:05 ET
Dynavax GAAP EPS of $0.00 Beats by $0.01, Revenue of $55.6M Beats by $2.87M
Seeking AlphaFeb 22 16:02 ET
Dynavax 4Q Rev $55.6M >DVAX
Dynavax 4Q Rev $55.6M >DVAX
Dow JonesFeb 22 16:01 ET
Press Release: Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance PR Newswire EMERYVILLE, Calif., Feb. 22, 2024 -- HEPLISAV-B(R) 2023 net product
Dow JonesFeb 22 16:01 ET
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. • Bausch Health Companies (NYSE:BHC) is expected t
BenzingaFeb 22 05:27 ET
No Data
No Data